Literature DB >> 9255152

FDG-PET appearance of pelvic Castleman's disease.

S P Murphy1, M A Nathan, M W Karwal.   

Abstract

We report a case of Castleman's disease demonstrating 18F-fluorodeoxyglucose (FDG) localization by whole-body PET imaging in a pelvic soft-tissue mass shown on abdominopelvic CT. In this case, there is mild FDG localization within pelvic Castleman's disease with standard uptake values lower than in many cases of low-grade and intermediate-grade lymphomas previously reported. FDG-PET may be of value as an imaging modality for differentiating Castleman's disease from lymphoma.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9255152

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


  10 in total

1.  FDG-PET/CT imaging in the management of HIV-associated multicentric Castleman's disease.

Authors:  Rob Barker; Fahrad Kazmi; Justin Stebbing; Sarah Ngan; Roger Chinn; Mark Nelson; Michael O'Doherty; Mark Bower
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-12-03       Impact factor: 9.236

2.  FDG-PET imaging in the diagnosis of HIV-associated multicentric Castleman disease: something is still missing.

Authors:  Roberto Rossotti; Christina Moioli; Clara Schiantarelli; Carloandrea Orcese; Massimo Puoti
Journal:  Top Antivir Med       Date:  2012 Aug-Sep

Review 3.  Clinical features and outcome of patients with HIV-negative multicentric Castleman's disease treated with combination chemotherapy: a report on 10 patients.

Authors:  Shou-Hui Zhu; Yong-Hua Yu; Yong Zhang; Ju-Jie Sun; Da-Li Han; Jia Li
Journal:  Med Oncol       Date:  2013-02-12       Impact factor: 3.064

4.  Retroperitoneal Castleman's Disease.

Authors:  Kota Shimokihara; Takashi Kawahara; Ryo Kasahara; Jun Kasuga; Shinpei Sugiura; Ryosuke Tajiri; Hiroji Uemura; Kimio Chiba
Journal:  Case Rep Oncol       Date:  2019-11-27

5.  Surgical management of abdominal and retroperitoneal Castleman's disease.

Authors:  Pascal Bucher; Gilles Chassot; Guillaume Zufferey; Frederic Ris; Olivier Huber; Philippe Morel
Journal:  World J Surg Oncol       Date:  2005-06-07       Impact factor: 2.754

6.  Fluorodeoxyglucose-positron emission tomography/computed tomography in the staging and evaluation of treatment response in a patient with Castleman's disease: a case report.

Authors:  Ettore Pelosi; Andrea Skanjeti; Angelina Cistaro; Vincenzo Arena
Journal:  J Med Case Rep       Date:  2008-04-03

7.  Multimodal imaging and clinical characteristics of bone lesions in POEMS syndrome.

Authors:  Xiao-Feng Shi; Shu-Dong Hu; Jun-Min Li; Xian-Fu Luo; Zhang-Biao Long; Yan Zhu; Xiao-Dong Xi
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 8.  Emerging role of 18F-FDG PET/CT in Castleman disease: a review.

Authors:  Benjamin Koa; Austin J Borja; Mahmoud Aly; Sayuri Padmanabhan; Joseph Tran; Vincent Zhang; Chaitanya Rojulpote; Sheila K Pierson; Mark-Avery Tamakloe; Johnson S Khor; Thomas J Werner; David C Fajgenbaum; Abass Alavi; Mona-Elisabeth Revheim
Journal:  Insights Imaging       Date:  2021-03-11

9.  Unicentric mixed variant Castleman disease associated with Hashimoto disease: the role of PET/CT in staging and evaluating response to the treatment.

Authors:  Cengiz Akosman; Nalan Alan Selcuk; Cetin Ordu; Sina Ercan; Isin Dogan Ekici; Basak Oyan
Journal:  Cancer Imaging       Date:  2011-06-15       Impact factor: 3.909

10.  Osteosarcoma Manifesting Systemic Inflammation and Histological Features Mimicking Plasma Cell-type Castleman Disease.

Authors:  Shino Fujimoto; Tomoyuki Sakai; Hiroshi Kawabata; Nozomu Kurose; Sohsuke Yamada; Mariko Doai; Munetaka Matoba; Haruka Iwao-Kawanami; Takafumi Kawanami; Shuichi Mizuta; Toshihiro Fukushima; Hiroki Mizumaki; Masaki Yamaguchi; Yasufumi Masaki
Journal:  Intern Med       Date:  2019-06-07       Impact factor: 1.271
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.